Featured Research

from universities, journals, and other organizations

Aspirin And Other Non-Specific Cox Inhibitors May Slow Atherosclerosis

Date:
March 14, 2001
Source:
University Of Pennsylvania Medical Center
Summary:
New research by scientists at the University of Pennsylvania School of Medicine has demonstrated that aspirin, ibuprofen and other drugs in the class of pharmaceuticals known as non-specific COX inhibitors may aid substantially in preventing heart disease, slowing the build-up of plaque in blood vessels by more than 50 percent.

Making sure cardiac patients take an aspirin a day to prevent a second heart attack is part of established treatment for most physicians, and many recommend the same regimen for patients at risk of suffering a first attack. But there has never been scientific evidence to demonstrate that this common, over-the-counter medication really provides any benefit in staving off the underlying condition of atherosclerosis.

Related Articles


Now, mouse-model research by scientists at the University of Pennsylvania School of Medicine has demonstrated that aspirin, ibuprofen and other drugs in the class of pharmaceuticals known as non-specific COX inhibitors may aid substantially in preventing heart disease, slowing the build-up of plaque in blood vessels by more than 50 percent.

"This study suggests that a product of the cyclooxegenase enzyme known as COX-1 -- which is the form targeted by aspirin in the prevention of heart attacks -- may also have a part to play in the gradual hardening of the arteries that precedes acute events like heart attack or stroke," said Garret A. FitzGerald, MD, chairman of Penn’s Department of Pharmacology. The research will be published March 13 in the Proceedings of the National Academy of Science.

The study also demonstrates that a separate class of drugs that specifically target the COX-2 enzyme -- so-called "super aspirins" such as Celebrex and Vioxx -- do not speed up the development of atherosclerosis, a concern based on some biochemical effects of those drugs. In their work, the Penn scientists scrutinized both known forms of the enzyme cyclooxygenase: COX-1, which is present throughout the body, and COX-2, which is present in some tissues, including the lining of the blood vessels.

COX-1 is the only form of the enzyme in platelets -- blood cells that stick together in the first stages of clotting. Suppression of the platelet COX-1 product, thromboxane, is how aspirin protects against heart attack and stroke.

The COX-2 enzyme produces prostacyclin, a hormone-like substance that might work against atherosclerosis by keeping blood vessels elastic, slowing the division of cells in the blood vessel wall, and preventing blood clots. On the other hand, prostacyclin is also pro-inflammatory -- a property that may speed up atherosclerosis. Before the experiment, it was impossible to know how these conflicting effects would play out when COX-2 inhibitors were given.

When they were introduced a few years ago as anti-inflammatories, the COX-2 inhibitors quickly became popular for treating illnesses such as arthritis. But because of the properties of prostacyclin, FitzGerald and his colleagues wondered whether blocking this COX-2 product might lead to hardening of the arteries, particularly in young patients with juvenile arthritis who might take the drug for long periods.

Using mice that had been engineered to produce high levels of cholesterol, the scientists injected one group with the non-specific inhibitor indomethacin, a second group with the COX-2 blocker nimesulide, and a third control group with a placebo. Analyzing the mice’s aortas at the conclusion of the 16-weeks study, the researchers found that atherosclerotic lesions were reduced by 55 percent in mice exposed to the non-specific COX inhibitor, compared to lesions in the untreated mice. Mice exposed to the COX-2 inhibitor showed the same progression of atherosclerosis as the control group.

"Because prostacyclin is potentially pro-inflammatory, inhibiting it might have proved beneficial, and there was a hint of that in our data. But it did not attain significance – in fact the effects of inhibiting prostacyclin paled in comparison with the use of a mixed inhibitor," FitzGerald said.

"The real story is that atherosclerosis is not only inflammation. There is something else at work here, and that is the production of thromboxane by COX-1," added Domenico Pratico, MD, a research assistant professor of Pharmacology at Penn who collaborated with FitzGerald in the study.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Aspirin And Other Non-Specific Cox Inhibitors May Slow Atherosclerosis." ScienceDaily. ScienceDaily, 14 March 2001. <www.sciencedaily.com/releases/2001/03/010308072254.htm>.
University Of Pennsylvania Medical Center. (2001, March 14). Aspirin And Other Non-Specific Cox Inhibitors May Slow Atherosclerosis. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2001/03/010308072254.htm
University Of Pennsylvania Medical Center. "Aspirin And Other Non-Specific Cox Inhibitors May Slow Atherosclerosis." ScienceDaily. www.sciencedaily.com/releases/2001/03/010308072254.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
Dads-To-Be Also Experience Hormone Changes During Pregnancy

Dads-To-Be Also Experience Hormone Changes During Pregnancy

Newsy (Dec. 18, 2014) A study from University of Michigan researchers found that expectant fathers see a decrease in testosterone as the baby's birth draws near. Video provided by Newsy
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins